Automating a Magnetic 3D Spheroid Model Technology for High-Throughput Screening.
3D printing
HTS
magnetic bioprinting
organoid
spheroid
Journal
SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
22
6
2019
medline:
10
4
2020
entrez:
22
6
2019
Statut:
ppublish
Résumé
Affordable and physiologically relevant three-dimensional (3D) cell-based assays used in high-throughput screening (HTS) are on the rise in early drug discovery. These technologies have been aided by the recent adaptation of novel microplate treatments and spheroid culturing techniques. One such technology involves the use of nanoparticle (NanoShuttle-PL) labeled cells and custom magnetic drives to assist in cell aggregation to ensure rapid 3D structure formation after the cells have been dispensed into microtiter plates. Transitioning this technology from a low-throughput manual benchtop application, as previously published by our lab, into a robotically enabled format achieves orders of magnitude greater throughput but required the development of specialized support hardware. This effort included in-house development, fabrication, and testing of ancillary devices that assist robotic handing and high-precision placement of microtiter plates into an incubator embedded with magnetic drives. Utilizing a "rapid prototyping" approach facilitated by cloud-based computer-aided design software, we built the necessary components using hobby-grade 3D printers with turnaround times that rival those of traditional manufacturing/development practices at a substantially reduced cost. This approach culminated in a first-in-class HTS-compatible 3D system in which we have coupled 3D bioprinting to a fully automated HTS robotic platform utilizing our novel magnetic incubator shelf assemblies.
Identifiants
pubmed: 31225974
doi: 10.1177/2472630319854337
pmc: PMC7704036
mid: NIHMS1648664
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
420-428Subventions
Organisme : NCI NIH HHS
ID : R33 CA206949
Pays : United States
Références
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
PLoS Biol. 2015 Mar 20;13(3):e1002086
pubmed: 25794301
Talanta. 2018 Jan 15;177:74-76
pubmed: 29108585
SLAS Discov. 2017 Jun;22(5):456-472
pubmed: 28520521
Biofabrication. 2012 Sep;4(3):035001
pubmed: 22728820
J Biomol Screen. 2013 Dec;18(10):1298-308
pubmed: 23918920
Tissue Eng Part C Methods. 2013 Sep;19(9):665-75
pubmed: 23301612
Oncogene. 2018 Aug;37(32):4372-4384
pubmed: 29743592
Trends Biotechnol. 2013 Feb;31(2):108-15
pubmed: 23336996
Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45
pubmed: 17684528
Tissue Eng Part C Methods. 2013 May;19(5):336-44
pubmed: 23017116
Nat Nanotechnol. 2010 Apr;5(4):291-6
pubmed: 20228788
J Lab Autom. 2016 Aug;21(4):489-95
pubmed: 27197798
J Biotechnol. 2010 Jul 1;148(1):3-15
pubmed: 20097238
Cell. 2015 Jan 15;160(1-2):324-38
pubmed: 25557080
Acta Biomater. 2014 Jan;10(1):173-82
pubmed: 24036238
SLAS Discov. 2017 Jun;22(5):516-524
pubmed: 28346088
J Lab Autom. 2016 Aug;21(4):568-78
pubmed: 26203054
Adv Drug Deliv Rev. 2014 Apr;69-70:29-41
pubmed: 24636868
Small. 2005 Mar;1(3):325-7
pubmed: 17193451
SLAS Discov. 2018 Sep;23(8):842-849
pubmed: 29750582
SLAS Discov. 2018 Jul;23(6):574-584
pubmed: 29673279
Pharmacol Ther. 2016 Jul;163:94-108
pubmed: 27063403
BMC Cancer. 2013 Feb 27;13:95
pubmed: 23446043
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:6805-8
pubmed: 23367492
Sci Rep. 2015 Sep 14;5:13987
pubmed: 26365200
Trends Biotechnol. 2017 Feb;35(2):133-144
pubmed: 27634310